Alkermes plc (ALKS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 10:59AM EDT. Market open.
| Previous Close | 24.01 |
| Open | 23.87 |
| Bid | 23.63 x 600 |
| Ask | 23.73 x 300 |
| Day's Range | 23.51 - 23.87 |
| 52 Week Range | 22.01 - 33.71 |
| Volume | |
| Avg. Volume | 2,063,827 |
| Market Cap | 4.006B |
| Beta (5Y Monthly) | 0.55 |
| PE Ratio (TTM) | 7.74 |
| EPS (TTM) | 3.06 |
| Earnings Date | Jul 22, 2024 - Jul 26, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 34.73 |
PR NewswireAlkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. In connection with the closing of the transaction, Alkermes will receive a one-time cash payment for the facility and certain related assets of approximately $91 million.
ZacksAlkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Alkermes (ALKS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksAlkermes (ALKS) Q1 Earnings and Revenues Miss Estimates
Alkermes (ALKS) delivered earnings and revenue surprises of -25.42% and 2.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.